P10646 (TFPI1_HUMAN) Homo sapiens (Human)
Tissue factor pathway inhibitor UniProtKBInterProSTRINGInteractive Modelling
304 aa; Sequence (Fasta) ; (Isoform 2)
Available Structures
8 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| KD1 of human TFPI in complex with a synthetic peptide |
Heteromer | |||||
| Assess | ||||||
| Crystal structure of 2F22 Fab fragment against TFPI1 |
Heteromer | 4×GOL; | ||||
| Assess | ||||||
| Hemostatic effect of a monoclonal antibody mAb 2021 blocking the interaction between FXa and TFPI i… |
Heteromer | 10×GOL; 1×MES; 3×PGE; | ||||
| Assess | ||||||
| Structure of the Clade 2 C. difficile TcdB in complex with its receptor TFPI |
Heteromer Q9EXR0; | |||||
| Assess | ||||||
| COMPLEX OF THE SECOND KUNITZ DOMAIN OF TISSUE FACTOR PATHWAY INHIBITOR WITH PORCINE TRYPSIN |
Heteromer P00761; | 1×CA; | ||||
| Assess | ||||||
| Human Mesotrypsin (PRSS3) Complexed with Tissue Factor Pathway Inhibitor Variant (TFPI1-KD1-K15R-I1… |
Heteromer P35030; | 1×SO4; | ||||
| Assess | ||||||
| THE SOLUTION STRUCTURE OF THE SECOND KUNITZ DOMAIN OF TISSUE FACTOR PATHWAY INHIBITOR, NMR, 30 STRU… | monomer | |||||
| Assess | ||||||
| The Solution Structure of The Third Kunitz Domain of Tissue Factor Pathway Inhibitor | monomer | |||||
| Assess | ||||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 4bqd.1.A | monomer | 0.65 | 100.00 | |||
| Assess | ||||||
| 4bd9.1.B | monomer | 0.54 | 39.45 | |||
| Assess | ||||||
2 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 4bqd.1.A | monomer | 0.64 | 100.00 | ||
| Assess | ||||||
| Isoform 2 | 7v1n.1.B | monomer | 0.56 | 100.00 | ||
| Assess | ||||||